Vidar System, widely known as a manufacturer of medical film digitizers, has been acquired by Contex Holdings of Allerød, Denmark. Contex, a maker of large-format scanners, is owned by EQT, a group of Scandinavian private equity funds. Contex and Vidar
Vidar System, widely known as a manufacturer of medical film digitizers, has been acquired by Contex Holdings of Allerød, Denmark. Contex, a maker of large-format scanners, is owned by EQT, a group of Scandinavian private equity funds. Contex and Vidar have been competitors in the development and distribution of large-format image scanning equipment. Vidar has also established itself as the leading producer of medical x-ray digitizers for diagnosis and treatment applications. The merged company will have combined revenues for 2002 exceeding US$50 million. Strategists plan to focus on the medical imaging products segment, while Contex concentrates on large-format imaging applications. Vidar will continue to design, develop, and distribute its range of medical products under Vidar brand from its facility in Herndon, VA.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Strategies to Reduce Disparities in Interventional Radiology Care
March 19th 2025In order to help address the geographic, racial, and socioeconomic barriers that limit patient access to interventional radiology (IR) care, these authors recommend a variety of measures ranging from increased patient and physician awareness of IR to mobile IR clinics and improved understanding of social determinants of health.
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.